Physician profile
Brian J Brown
NPI 1639494339
$389,409.86
in general payments reported to CMS, 2019-2025
52 companies · $104K in 2025
The $104K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,772 · 2020: $655 · 2021: $13K · 2022: $54K · 2023: $117K · 2024: $99K · 2025: $104K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $205K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $65K · Travel and Lodging: $28K · Food and Beverage: $23K · Gift: $948 · Entertainment: $32.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $204,541.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $64,675.00 |
| Travel and Lodging | $27,529.39 |
| Food and Beverage | $22,542.32 |
| Gift | $947.83 |
| Entertainment | $32.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shimadzu Precision Instruments, INC. | $158,417.69 | 2021-2025 | |
| Inari Medical, INC. | $93,574.18 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cms Imaging, INC. | $68,632.09 | 2021-2025 | |
| Medtronic, INC. | $21,656.42 | 2021-2025 | In.Pact Admiral, Hawkone, Corevalve Evolut R |
| Recor Medical INC | $15,794.80 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Stryker Corporation | $13,589.44 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Abbott Laboratories | $3,592.04 | 2019-2025 | Esprit, Diamondback Coronary, Acculink |
| Boston Scientific Corporation | $2,686.49 | 2019-2025 | Avvigo Guidance System, General - Balloon Catheters, Opticross |
| Cardiovascular Systems INC. | $1,650.86 | 2019-2023 | Diamondback Coronary |
| Abiomed | $1,550.55 | 2019-2025 | Impella |
| Infraredx, INC. | $1,000.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $786.79 | 2019-2025 | |
| Cvrx, INC. | $642.25 | 2023-2025 | Barostim Neo System |
| Endologix LLC | $538.70 | 2024-2025 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| Medtronic Vascular, INC. | $481.03 | 2019-2020 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $475.46 | 2022-2025 | Auryon Laser System 100-120 Vac, Alphavac, Angiovac |
| Astrazeneca Pharmaceuticals Lp | $453.55 | 2019-2024 | Farxiga, Wainua |
| Imperative Care, INC | $438.83 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Pfizer INC. | $284.44 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $257.36 | 2019-2025 | Lifevest |
| Atricure, INC. | $254.30 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Janssen Pharmaceuticals, INC | $237.66 | 2020-2023 | Xarelto |
| Philips North America LLC | $220.36 | 2021-2024 | (Br0) Coronary Atherectomy, (9282) Turbo Power |
| E.R. Squibb & Sons, L.L.C. | $200.14 | 2022-2025 | Camzyos, Eliquis |
| Avantec Vascular Corporation | $181.05 | 2024 | |
| Edwards Lifesciences Corporation | $154.13 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Vasorum USA INC. | $145.03 | 2022-2023 | Celt Acd |
| Merck Sharp & Dohme LLC | $131.62 | 2021-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $126.61 | 2023 | Optimizer |
| Biotronik INC. | $126.40 | 2019-2023 | Orsiro Mission |
| Asahi Intecc USA, INC. | $120.54 | 2025 | Asahi Interventional Radiology Wires |
| Shockwave Medical, INC | $117.03 | 2021-2022 | |
| Amgen INC. | $96.06 | 2021-2025 | Repatha, Repatha |
| Becton, Dickinson and Company | $96.04 | 2025 | Hemosphere, Vitawave |
| Alnylam Pharmaceuticals INC. | $90.05 | 2021-2025 | Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.39 | 2019-2022 | |
| Tactile Systems Technology INC | $77.35 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Gilead Sciences, INC. | $74.04 | 2023 | |
| Thrombolex, INC. | $69.51 | 2024 | Bashir Endovascular Catheter |
| Daiichi Sankyo INC. | $42.57 | 2023-2024 | Injectafer |
| Cagent Vascular INC | $39.48 | 2025 | Serrantor |
| Change Healthcare Technologies, LLC | $36.14 | 2020 | |
| Heartflow, INC. | $29.21 | 2025 | |
| Chiesi USA, INC. | $28.91 | 2022 | |
| Cardiva Medical, INC. | $23.63 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.95 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, Ltd. | $18.41 | 2023 | Arcalyst |
| Novo Nordisk INC | $14.91 | 2025 | Wegovy |
| Getinge USA Sales, LLC | $14.71 | 2021 | |
| Terumo Medical Corporation | $14.52 | 2023 | Heartrail, Glidewire |
| Sanofi-Aventis U.S. LLC | $13.59 | 2023 | |
| Cardinal Health 200 LLC | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.